The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 3,143 216,143 SH   SOLE   216,143 0 0
ASTRAZENECA PLC SPONSORED ADR 046353108 29,819 511,908 SH   SOLE   511,908 0 0
BIONTECH SE SPONSORED ADS 09075V102 23,217 90,057 SH   SOLE   90,057 0 0
CHEMOCENTRYX INC COM 16383L106 5,891 161,802 SH   SOLE   161,802 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 12,428 166,190 SH   SOLE   166,190 0 0
FATE THERAPEUTICS INC COM 31189P102 8,983 153,537 SH   SOLE   153,537 0 0
FULCRUM THERAPEUTICS INC COM 359616109 5,615 317,428 SH   SOLE   317,428 0 0
INHIBRX INC COM 45720L107 25,852 591,975 SH   SOLE   591,975 0 0
INTELLIA THERAPEUTICS INC COM 45826J105 71,605 605,587 SH   SOLE   605,587 0 0
KEROS THERAPEUTICS INC COM 492327101 6,524 111,500 SH   SOLE   111,500 0 0
PFIZER INC COM 717081103 454,553 7,697,762 SH   SOLE   7,697,762 0 0
VERVE THERAPEUTICS INC COM 92539P101 852 23,104 SH   SOLE   23,104 0 0
VIR BIOTECHNOLOGY INC COM 92764N102 6,106 145,841 SH   SOLE   145,841 0 0